Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"610"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Medical+Condition%3A+NSCLC%22&type=Subject&filter%5B%5D=topic_facet%3A%22610%22
/vufind/Search/Results?lookfor=%22Medical+Condition%3A+NSCLC%22&type=Subject&filter%5B%5D=topic_facet%3A%22610%22
Search /vufind/Search2/Results?lookfor=%22Medical+Condition%3A+NSCLC%22&type=Subject&filter%5B%5D=topic_facet%3A%22610%22
PubPharm (500)
1
Safety, Pharmacokinetics (PK), and Efficacy of ONC-392 in Advanced Solid Tumors and NSCLC: an Open Label Phase Ia/Ib Study. : Safety, Pharmacokinetics (PK), and Efficacy of ONC-392 in Advanced Solid Tumors and NSCLC: an Open Label Phase Ia/Ib Study.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Prognostic Indicators for Conventional Chemotherapy Response in Advanced Non-Small Cell Lung Cancer Patients in Resource-Limited Country : Prognostic Indicators for Conventional Chemotherapy Response in Advanced Non-Small Cell Lung Cancer Patients in Resource-Limited Country
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Efficacy and safety of adjuvant therapy of ensartinib in ALK-positive stage II-IIIB non-small cell lung cancer:a prospective, multicenter, single-arm phase II trial : Efficacy and safety of adjuvant therapy of ensartinib in ALK-positive stage II-IIIB non-small cell lung cancer:a prospective, multicenter, single-arm phase II trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
Non-interventive registration study on the treatment of advanced non-small cell lung cancer patients who had previously failed to receive PD-1/PD-L1 inhibitors with Anlotinib hydrochloride and PD-1/PD-L1 inhibitors : Non-interventive registration study on the treatment of advanced non-small cell lung cancer patients who had previously failed to receive PD-1/PD-L1 inhibitors with Anlotinib hydrochloride and PD-1/PD-L1 inhibitors
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A one-arm, prospective, phase II study of Surufatinib in combination with standard therapy in advanced solid tumors with neuroendocrine differentiation : A one-arm, prospective, phase II study of Surufatinib in combination with standard therapy in advanced solid tumors with neuroendocrine differentiation
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
Safety, Pharmacokinetics (PK), and Efficacy of ONC-392 in Advanced Solid Tumors and NSCLC: an Open Label Phase Ia/Ib Study. : Safety, Pharmacokinetics (PK), and Efficacy of ONC-392 in Advanced Solid Tumors and NSCLC: an Open Label Phase Ia/Ib Study.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Prognostic Indicators for Conventional Chemotherapy Response in Advanced Non-Small Cell Lung Cancer Patients in Resource-Limited Country : Prognostic Indicators for Conventional Chemotherapy Response in Advanced Non-Small Cell Lung Cancer Patients in Resource-Limited Country
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
Efficacy and safety of adjuvant therapy of ensartinib in ALK-positive stage II-IIIB non-small cell lung cancer:a prospective, multicenter, single-arm phase II trial : Efficacy and safety of adjuvant therapy of ensartinib in ALK-positive stage II-IIIB non-small cell lung cancer:a prospective, multicenter, single-arm phase II trial
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
Non-interventive registration study on the treatment of advanced non-small cell lung cancer patients who had previously failed to receive PD-1/PD-L1 inhibitors with Anlotinib hydrochloride and PD-1/PD-L1 inhibitors : Non-interventive registration study on the treatment of advanced non-small cell lung cancer patients who had previously failed to receive PD-1/PD-L1 inhibitors with Anlotinib hydrochloride and PD-1/PD-L1 inhibitors
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
A one-arm, prospective, phase II study of Surufatinib in combination with standard therapy in advanced solid tumors with neuroendocrine differentiation : A one-arm, prospective, phase II study of Surufatinib in combination with standard therapy in advanced solid tumors with neuroendocrine differentiation
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[50]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: 610
Medienart
500
Aufsätze
500
E-Artikel
500
E-Ressourcen
Zeitschriftentitel
290
WHO International Clinical Trials Registry Plat...
210
ClinicalTrials.gov
Thema
610
369
Study Type: Interventional
287
Medical Condition: NSCLC
140
Recruitment Status: Recruiting
135
Recruitment Status: Not yet recruiting
128
Carcinoma, Non-Small-Cell Lung
112
Phase: Phase 2
102
Study Type: Observational
87
Recruitment Status: Completed
43
Recruitment Status: Unknown status
39
Phase: Phase 3
35
Phase: Phase 1
28
Lung Neoplasms
28
Recruitment Status: Authorised-recruitment may ...
24
Recruitment Status: Complete: follow-up complete
22
Phase: Post-market
19
Phase: Phase 1/Phase 2
15
Recruitment Status: Terminated
14
Medical Condition: NSCLC Stage IV
14
Phase: Other
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
279
2020-
219
2010-2019
2
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
486
Englisch
10
Unbestimmt
4
Niederländisch
Haven't found what you're looking for?
Wird geladen...